Source:http://linkedlifedata.com/resource/pubmed/id/17075333
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2006-10-31
|
pubmed:abstractText |
New broader spectrum antifungal agents with favorable safety profiles have been available for the last 15 years making prophylaxis feasible. The purpose of this article is to review recent studies in patient populations at high risk for invasive fungal infections.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0951-7375
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
571-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading | |
pubmed:year |
2006
|
pubmed:articleTitle |
Antifungal prophylaxis for invasive mycoses in high risk patients.
|
pubmed:affiliation |
Third Department of Internal Medicine, Klinikum der Johannes Gutenberg-Universität, Mainz, Germany. ullmann@uni-mainz.de
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|